Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2 (original) (raw)
Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1
Olivier Schwartz
Journal of virology, 1998
View PDFchevron_right
Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology
TOMINAGA FUKAZAWA
Antimicrobial Agents and Chemotherapy, 1997
View PDFchevron_right
Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation
Charles Craik
Proceedings of the National Academy of Sciences, 1995
View PDFchevron_right
Active human immunodeficiency virus protease is required for viral infectivity
Emilio Emini
Proceedings of the …, 1988
View PDFchevron_right
Comparison of Human Immunodeficiency Virus Type 1 Pr55 Gag and Pr160 Gag-Pol Processing Intermediates That Accumulate in Primary and Transformed Cells Treated with Peptidic and Nonpeptidic Protease Inhibitors
Richard Collins III
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis
Ronald Luftig
Microbiology and Molecular Biology Reviews, 2000
View PDFchevron_right
How an Inhibitor of the HIV-I Protease Modulates Proteasome Activity
G. Schmidtke
Journal of Biological Chemistry, 1999
View PDFchevron_right
Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication
Jean-alain Fehrentz
Research in Virology, 1992
View PDFchevron_right
Selective Restriction of Nef-Defective Human Immunodeficiency Virus Type 1 by a Proteasome-Dependent Mechanism
Mingli Qi
Journal of Virology, 2007
View PDFchevron_right
Initial Cleavage of the Human Immunodeficiency Virus Type 1 GagPol Precursor by Its Activated Protease Occurs by an Intramolecular Mechanism
Ben Dunn
Journal of Virology, 2004
View PDFchevron_right
HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity
Krisztina Nikovics
Journal of Biological Chemistry, 2009
View PDFchevron_right
Processing sites in the human immunodeficiency virus type 1 (HIV1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates
Steve Pettit
Retrovirology, 2005
View PDFchevron_right
Human Immunodeficiency Virus gag and protease: partners in resistance
Monique Nijhuis
Retrovirology, 2012
View PDFchevron_right
Induced maturation of human immunodeficiency virus
Jan Konvalinka
Journal of virology, 2014
View PDFchevron_right
Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor
Petr Pachl, Jiří Schimer, Jan Weber
Nature Communications, 2015
View PDFchevron_right
Conserved Cysteines of the Human Immunodeficiency Virus Type 1 Protease Are Involved in Regulation of Polyprotein Processing and Viral Maturation of Immature Virions
David Davis
Journal of Virology, 1999
View PDFchevron_right
A peptide inhibitor of HIV-1 assembly in vitro
Ursula Dietrich
Nature Structural & Molecular Biology, 2005
View PDFchevron_right
Supplemental Data The Proteasome Regulates HIV1 Transcription by Both Proteolytic and Nonproteolytic Mechanisms
Marion Sourisseau
View PDFchevron_right
CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway
Igor Bacik
Journal of Virology, 1998
View PDFchevron_right
Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region
marina hutoran
The Journal of general virology, 2002
View PDFchevron_right
Inhibition of HIV1 replication by a peptide dimerization inhibitor of HIV1 protease
Cara Brown
Antiviral Research, 2006
View PDFchevron_right
The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles
Fu-der Wang
Virology, 2004
View PDFchevron_right
Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against the Initial Autocleavage in Gag-Pol Polyprotein Processing
David Davis, Ronald Desrosiers, Bruno Sargueil, Jules Deforges
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Elimination of Protease Activity Restores Efficient Virion Production to a Human Immunodeficiency Virus Type 1 Nucleocapsid Deletion Mutant
Elena Chertova
Journal of Virology, 2003
View PDFchevron_right
Proteasome inhibitors block HIV-1 replication by affecting both cellular and viral targets
Abdalla Hassan Ali Mohamed
Biochemical and Biophysical Research Communications, 2009
View PDFchevron_right
Antiviral agent based on the non-structural protein targeting the maturation process of HIV-1: expression and susceptibility of chimeric Vpr as a substrate for cleavage by HIV-1 protease
Irene Weber
Protein Engineering Design and Selection, 2000
View PDFchevron_right
The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors
Kenzo Tokunaga
Virology, 2010
View PDFchevron_right
Mechanisms of α1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis
Pierre Cordelier
Biochimica Et Biophysica Acta Molecular Basis of Disease, 2003
View PDFchevron_right
Double trouble? Gag in conjunction with double insert in HIV protease contributes to reduced DRV susceptibility
Yasien Sayed
Biochemical Journal, 2018
View PDFchevron_right
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor
Thomas Meek
Proceedings of the National Academy of Sciences, 1987
View PDFchevron_right
Fusion of uninfected T-cells occurs with immature HIV-1 protease-mutant, but not morphologically similar protease inhibitor derived particles
Ronald Luftig
Virus Research, 2000
View PDFchevron_right
Ordered Processing of the Human Immunodeficiency Virus Type 1 GagPol Precursor Is Influenced by the Context of the Embedded Viral Protease
jose clemente
Journal of Virology, 2005
View PDFchevron_right
Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation
Charles Craik
Antimicrobial Agents and Chemotherapy, 1994
View PDFchevron_right
Gag-Pol Processing during HIV-1 Virion Maturation: A Systems Biology Approach
Tamas Turanyi
PLoS Computational Biology, 2013
View PDFchevron_right
Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor
M. El-Farrash
Journal of Virology, 1994
View PDFchevron_right